World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
73
Citations
23740
World Ranking
1631
National Ranking
96

Jacques Reynes publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Jacques Reynes sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 396 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Jacques Reynes D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Jacques Reynes sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 73 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Jacques Reynes is affiliated with the University of Montpellier in France and has contributed extensively to the fields of Medicine and Immunology and Microbiology. Their research encompasses several subfields, including Infectious Diseases, Virology, Epidemiology, Sensory Systems, and Emergency Medicine.

The primary topics of their work focus on HIV, including HIV Research and Treatment, HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, and HIV-related health complications and treatments. In addition, they have contributed to research on reproductive tract infections as well as SARS-CoV-2 and COVID-19, including detection and testing methods.

Notable recent publications by Jacques Reynes include the following:

  • Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon, 2020, The Lancet HIV
  • Long-Acting Cabotegravir and Rilpivirine Dosed Every 2 Months in Adults With Human Immunodeficiency Virus 1 Type 1 Infection: 152-Week Results From ATLAS-2M, a Randomized, Open-Label, Phase 3b, Noninferiority Study, 2023, Clinical Infectious Diseases
  • Multiplex detection and dynamics of IgG antibodies to SARS-CoV2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV, 2020, Journal of Clinical Virology
  • Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies, 2020, Clinical and Translational Allergy
  • EasyCOV: LAMP based rapid detection of SARS-CoV-2 in saliva, 2020, bioRxiv (Cold Spring Harbor Laboratory)

Frequent co-authors collaborating with Jacques Reynes include:

  • Alain Makinson
  • Vincent Le Moing
  • David Morquin
  • Vincent Foulongne
  • Vincent Tribout

Jacques Reynes has published predominantly in several key venues such as:

  • Journal of Antimicrobial Chemotherapy
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Médecine et Maladies Infectieuses
  • Clinical Infectious Diseases
  • Frontiers in Immunology

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia.

    Adriano Lazzarin;Bonaventura Clotet;David Cooper;Jacques Reynes

  • Suppression of MicroRNA-Silencing Pathway by HIV-1 During Virus Replication

    Robinson Triboulet;Bernard Mari;Yea-Lih Lin;Christine Chable-Bessia

  • Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.

    Caroline Charlier;Élodie Perrodeau;Alexandre Leclercq;Alexandre Leclercq;Benoît Cazenave

  • Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population.

    Marianne Savès;Geneviève Chêne;Pierre Ducimetière;Catherine Leport

  • Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial

    Paul E. Sax;Anton Pozniak;M. Luisa Montes;Ellen Koenig

  • Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study

    Joseph J. Eron;Bonaventura Clotet;Jacques Durant;Christine Katlama

  • Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases.

    Hélène Peyriere;Jacques Reynes;Isabelle Rouanet;Nathalie Daniel

  • Mutations Associated with Failure of Raltegravir Treatment Affect Integrase Sensitivity to the Inhibitor In Vitro

    Isabelle Malet;Olivier Delelis;Marc-Antoine Valantin;Brigitte Montes

  • Suv39H1 and HP1γ are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency

    Isaure du Chéné;Euguenia Basyuk;Yea-Lih Lin;Robinson Triboulet

  • Chikungunya outbreak in Montpellier, France, September to October 2014.

    E Delisle;C Rousseau;B Broche;I Leparc-Goffart

  • CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses

    Benjamin Descours;Gaël Petitjean;José-Luis López-Zaragoza;José-Luis López-Zaragoza;Timothée Bruel;Timothée Bruel

  • Immune reconstitution under antiretroviral therapy: the new challenge in HIV-1 infection.

    Pierre Corbeau;Pierre Corbeau;Jacques Reynes

  • Phase II Trial of CHOP Plus Rituximab in Patients With HIV-Associated Non-Hodgkin's Lymphoma

    François Boué;Jean Gabarre;Christian Gisselbrecht;Jacques Reynes

  • CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1.

    Jacques Reynes;Pierre Portales;Michel Segondy;Vincent Baillat

  • Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial

    Joseph J. Eron;Jürgen K. Rockstroh;Jacques Reynes;Jaime Andrade-Villanueva

  • Long‐term assessment of neuropsychiatric adverse reactions associated with efavirenz

    P Lochet;H Peyrière;A Lotthé;J M Mauboussin

  • Optimized PCR using patient blood samples for diagnosis and follow-up of visceral Leishmaniasis, with special reference to AIDS patients.

    Laurence Lachaud;Jacques Dereure;Elisabeth Chabbert;Jacques Reynes

  • Visceral leishmaniasis and HIV-1 co-infection in southern France.

    Eric Rosenthal;Pierre Marty;Isabelle Poizot-Martin;Jacques Reynes

  • The yeast Candida albicans has a clonal mode of reproduction in a population of infected human immunodeficiency virus-positive patients.

    Claude Pujol;Jacques Reynes;Francois Renaud;Michel Raymond

  • Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study

    Hans Jürgen Stellbrink;Jacques Reynes;Adriano Lazzarin;Eugene Voronin

  • Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials

    Mark Nelson;Keikawus Arastéh;Bonaventura Clotet;David A. Cooper

  • Genetic Diversity of Protease and Reverse Transcriptase Sequences in Non-Subtype-B Human Immunodeficiency Virus Type 1 Strains: Evidence of Many Minor Drug Resistance Mutations in Treatment-Naive Patients

    Laurence Vergne;Martine Peeters;Eitel Mpoudi-Ngole;Anke Bourgeois

Frequent Co-Authors

Isabelle Poizot-Martin
Isabelle Poizot-Martin Aix-Marseille University
Eric Delaporte
Eric Delaporte University of Montpellier
André Cabié
André Cabié Grenoble Alpes University
Christine Katlama
Christine Katlama Sorbonne University
Jean-Michel Molina
Jean-Michel Molina Université Paris Cité
Cécile Goujard
Cécile Goujard University of Paris-Saclay
Jean Bousquet
Jean Bousquet University of Montpellier
Gilles Pialoux
Gilles Pialoux Tenon Hospital
Gilles Peytavin
Gilles Peytavin Claude Bernard University Lyon 1

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse healthcare and scientific careers, many of which now integrate essential skills in data management and coding. One promising route is becoming a certified professional coder, an area that demands specialized training and offers a structured career path with competitive salaries. Those interested can explore detailed guidance on certified professional coder certification to understand the requirements and benefits of this role.

Another career trajectory involves health information management, combining microbiological knowledge with expertise in maintaining and securing patient data. Health information managers enjoy growing demand and attractive compensation, with job specifics outlined in the article on health information management jobs salary. This field often requires a formal degree recognized by industry standards.

For students seeking reliable education options, pursuing an accredited online health information management degree cahiim ensures quality training and better career prospects. These programs cover essential topics that complement microbiology studies by emphasizing compliance, data accuracy, and healthcare systems management.

Additionally, those pressed for time or looking to quickly enter the workforce may consider fast-track options like fast online medical billing and coding certification programs. These certificate programs accelerate credentialing, equipping students with practical skills necessary for immediate employment in medical offices, hospitals, and related settings.

Best Scientists Citing Jacques Reynes

Trending Scientists

Recently Published Articles